Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2024-08-14 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, which pertains to share certificate management. The content is about notifying the exchanges of a corporate action related to share certificates, specifically the issuance of duplicates, and includes details such as folio numbers, certificate numbers, and share counts. This is a regulatory announcement about share certificates, not a financial report, management change, or voting result. It does not contain financial data or results, nor is it a report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-14 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of un-audited standalone and consolidated financial results in newspapers, pursuant to SEBI regulations. It mentions that the financial results were published in newspapers on a specific date. The document itself does not contain the full financial statements or detailed financial analysis but serves as a notification of the publication of these results. The document length is short (1913 characters), and it primarily announces the availability of the financial results rather than presenting the report itself. According to the 'Menu vs Meal' rule, such a document is classified as a Report Publication Announcement (RPA).
2024-08-12 English
The Company enclosed the newspaper publication of the unaudited standalone and consolidated financial results in newspapers, as enclosed.
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of un-audited standalone and consolidated financial results in newspapers, pursuant to SEBI regulations. It mentions the financial results were published on 10th August 2024 in newspapers but does not contain the full financial statements or detailed financial analysis itself. The document length is short (1913 characters) and primarily serves as a notification of publication rather than the report itself. According to the 'Menu vs Meal' rule, this is an announcement of a report publication, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2024-08-12 English
Scrutinizer Report for the Annual General Meeting of the Company held on 09.08.2024
Regulatory Filings
2024-08-09 English
Shareholders meeting
Regulatory Filings
2024-08-09 English
Proceedings of Annual General Meeting held on 09th August 2024
Regulatory Filings
2024-08-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.